| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE | 4 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION USP, 2% (Viscous) | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VISTIDE ® (cidofovir injection) | 6 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | Amerisource Bergen Eye Itch Relief Drug Facts | 7 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | These highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959 | 7 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | Drug Facts | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 82f5292b-b113-4f10-9469-04386fa8e9d4 | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3959 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | GENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPY DBA QUALITY CARE PRODUCTS LLC] | 3884 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LIDOCAINE HYDROCHLORIDE SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3874 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE) SUSPENSION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3864 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | PATADAY (OLOPATADINE HYDROCHLORIDE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3728 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3642 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3311 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ZIPSOR (DICLOFENAC POTASSIUM) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS] | 2043 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DEPACON (VALPROATE SODIUM) INJECTION [ABBVIE INC.] | 1531 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | MIVACRON (MIVACURIUM CHLORIDE) SOLUTION [ABBVIE INC.] | 1419 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CALCIJEX (CALCITRIOL) INJECTION, SOLUTION [ABBVIE INC.] | 1415 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | PHENYLEPHRINE HYDROCHLORIDE SOLUTION [BRYANT RANCH PREPACK] | 1001 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUDEPRION (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NPLATE (ROMIPLOSTIM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMGEN INC] | 124 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION HUMALOG KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 49 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 44 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 37 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | OPTIRAY 350 (IOVERSOL) INJECTION OPTIRAY 320 (IOVERSOL) INJECTION OPTIRAY 300 (IOVERSOL) INJECTION OPTIRAY 240 (IOVERSOL) INJECTION [MALLINCKRODT INC.] | 33 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY] | 32 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY
] | 31 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | PREZISTA (DARUNAVIR) TABLET, FILM COATED PREZISTA (DARUNAVIR) SUSPENSION [JANSSEN PRODUCTS LP] | 31 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | OPTIMARK (GADOVERSETAMIDE) INJECTION, SOLUTION [MALLINCKRODT INC.] | 30 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 29 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | AVELOX (MOXIFLOXACIN HYDROCHLORIDE) INJECTION, SOLUTION AVELOX (MOXIFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED [SCHERING PLOUGH CORPORATION] | 26 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.] | 26 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | VIMPAT (LACOSAMIDE) TABLET, FILM COATED VIMPAT (LACOSAMIDE) KIT VIMPAT (LACOSAMIDE) INJECTION VIMPAT (LACOSAMIDE) SOLUTION [UCB, INC.] | 26 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION CLEOCIN PHOSPHATE (0009-6582) (STANDALONE) (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 25 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 23 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [X-GEN PHARMACEUTICALS, INC.] | 22 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | DESMOPRESSIN ACETATE SOLUTION [FERRING PHARMACEUTICALS INC.] | 22 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | EMEND (FOSAPREPITANT DIMEGLUMINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY
] | 22 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | LANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 22 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOXAFIL (POSACONAZOLE) SUSPENSION NOXAFIL (POSACONAZOLE) TABLET, COATED NOXAFIL (POSACONAZOLE) SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | OPTIRAY PHARMACY BULK PACKAGE - 350 (IOVERSOL) INJECTION OPTIRAY PHARMACY BULK PACKAGE - 320 (IOVERSOL) INJECTION OPTIRAY PHARMACY BULK PACKAGE - 300 (IOVERSOL) INJECTION [MALLINCKRODT INC.] | 22 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | TEMODAR (TEMOZOLOMIDE) CAPSULE TEMODAR (TEMOZOLOMIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PAR PHARMACEUTICAL, INC.] | 21 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VOLUVEN (HYDROXYETHYL STARCH 130/0.4) INJECTION, SOLUTION [HOSPIRA INC.] | 21 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 5756-20 CONTINUOUS EPIDURAL 18G HUSTEAD () KIT [SMITHS MEDICAL ASD, INC.] | 20 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CAMPTOSAR (IRINOTECAN HYDROCHLORIDE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 20 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VIBRAMYCIN MONOHYDRATE (DOXYCYCLINE) POWDER, FOR SUSPENSION VIBRAMYCIN CALCIUM (DOXYCYCLINE CALCIUM) SYRUP VIBRAMYCIN HYCLATE (DOXYCYCLINE HYCLATE) CAPSULE VIBRA-TABS (DOXYCYCLINE HYCLATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 20 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | XOPENEX (LEVALBUTEROL HYDROCHLORIDE) SOLUTION, CONCENTRATE [SUNOVION PHARMACEUTICALS INC.] | 20 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [X-GEN PHARMACEUTICALS, INC.] | 19 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | HEPARIN SODIUM INJECTION [SAGENT PHARMACETICALS] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE) SPRAY, METERED [CHATTEM, INC.] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | OPTIMARK (GADOVERSETAMIDE) INJECTION, SOLUTION [MALLINCKRODT INC.] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ZOSYN (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ZOSYN IN GALAXY CONTAINERS (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ZOSYN (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ZOSYN PHARMACY BULK PACKAGE (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ZOSYN IN GALAXY CONTAINERS (TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM) INJECTION, SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 18 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | GEMZAR (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY
] | 18 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 18 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 17 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS] | 17 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] | 17 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 17 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 17 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ARISTOSPAN (TRIAMCINOLONE HEXACETONIDE) INJECTION, SUSPENSION [SANDOZ INC] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 16 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | GRANISETRON HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GRANISETRON INJECTION [SANDOZ INC] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | SPORANOX (ITRACONAZOLE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VALPROIC ACID SOLUTION [QUALITEST PHARMACEUTICALS] | 16 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | ZEMAIRA (ALPHA-1-PROTEINASE INHIBITOR HUMAN) KIT [CSL BEHRING LLC] | 16 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPIVACAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 15 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | DOXEPIN HYDROCHLORIDE SOLUTION [SILARX PHARMACEUTICALS, INC] | 15 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | DOXIL (DOXORUBICIN HYDROCHLORIDE) INJECTION, SUSPENSION, LIPOSOMAL [JANSSEN PRODUCTS, LP] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GALLIUM (GALLIUM CITRATE GA-67) INJECTION [LANTHEUS MEDICAL IMAGING, INC.] | 15 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | GRANISETRON HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 15 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HEPARIN SODIUM INJECTION [SAGENT PHARMACEUTICALS] | 15 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HUMULIN R U-500 (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY
] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ISOLYTE P IN DEXTROSE (DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | KETOROLAC TROMETHAMINE INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | KETOROLAC TROMETHAMINE INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | LEVAQUIN (LEVOFLOXACIN) TABLET, FILM COATED LEVAQUIN (LEVOFLOXACIN) SOLUTION LEVAQUIN (LEVOFLOXACIN) INJECTION, SOLUTION [JANSSEN PHARMACEUTICALS, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | MARCAINE SPINAL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NALOXONE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NORDITROPIN (SOMATROPIN) INJECTION, SOLUTION [NOVO NORDISK] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NORMOSOL-M AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM ACETATE, AND MAGNESIUM ACETATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CEFTRIAXONE (CEFTRIAXONE SODIUM) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) INJECTION, SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | KETOROLAC TROMETHAMINE INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | KETOROLAC TROMETHAMINE INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LACTATED RINGERS AND DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION LACTATED RINGERS (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | METOCLOPRAMIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | MIDAZOLAM HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | OXCARBAZEPINE SUSPENSION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | QUELICIN (SUCCINYLCHOLINE CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | REMODULIN (TREPROSTINIL) INJECTION, SOLUTION [UNITED THERAPEUTICS CORPORATION] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | RINGERS (SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE) INJECTION, SOLUTION RINGERS AND DEXTROSE (SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | SODIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 14 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | ZALTRAP (ZIV-AFLIBERCEPT) SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC] | 14 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ABLAVAR (GADOFOSVESET TRISODIUM) INJECTION, SOLUTION [LANTHEUS MEDICAL IMAGING, INC.] | 13 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ACETYLCYSTEINE SOLUTION [HOSPIRA, INC.] | 13 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | AMINOSYN (ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, TYROSINE, AND GLYCINE) INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |